Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward M Gardner

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
AIDS Research and Human Retroviruses|September 1, 2012
Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposureJose R Castillo-Mancilla, Jia-Hua Zheng, Joseph E Rower, et al.
AIDS Research and Human Retroviruses|June 18, 2019
Short Communication: Cascade of Antiretroviral Therapy Adherence in Virologically Suppressed Persons Living with HIVJose R Castillo-Mancilla, Ryan P Coyle, Stacey S Coleman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 2, 2021
Risk Factors for Hospitalization in People With HIV and COVID-19Kevin F Kamis, Lauren Barbera, Mona Abdo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 24, 2018
Tenofovir Diphosphate in Dried Blood Spots Is Strongly Associated With Viral Suppression in Individuals With Human Immunodeficiency Virus InfectionsJose R Castillo-Mancilla, Mary Morrow, Ryan P Coyle, et al.
The Journal of Infectious Diseases|April 4, 2019
Predictive Value of Tenofovir Diphosphate in Dried Blood Spots for Future Viremia in Persons Living With HIVMary Morrow, Samantha MaWhinney, Ryan P Coyle, et al.
The Journal of Antimicrobial Chemotherapy|March 27, 2020
Factors associated with tenofovir diphosphate concentrations in dried blood spots in persons living with HIVRyan P Coyle, Mary Morrow, Stacey S Coleman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 13, 2015
Reduced immune activation during tenofovir-emtricitabine therapy in HIV-negative individualsJose R Castillo-Mancilla, Amie Meditz, Cara Wilson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 24, 2016
Suboptimal Adherence to Combination Antiretroviral Therapy Is Associated With Higher Levels of Inflammation Despite HIV SuppressionJose R Castillo-Mancilla, Todd T Brown, Kristine M Erlandson, et al.
BMC Infectious Diseases|January 14, 2025
Blood absolute lymphocyte count and trajectory are important in understanding severe COVID-19Catharine I Paules, Jacqueline A Nordwall, Kathryn Shaw-Saliba, et al.
AIDS and Behavior|February 25, 2019
Engagement in Mental Health Care is Associated with Higher Cumulative Drug Exposure and Adherence to Antiretroviral TherapyRyan P Coyle, Christopher D Schneck, Mary Morrow, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
AIDS Research and Human Retroviruses|September 1, 2012
Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposureJose R Castillo-Mancilla, Jia-Hua Zheng, Joseph E Rower, et al.
AIDS Research and Human Retroviruses|June 18, 2019
Short Communication: Cascade of Antiretroviral Therapy Adherence in Virologically Suppressed Persons Living with HIVJose R Castillo-Mancilla, Ryan P Coyle, Stacey S Coleman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 2, 2021
Risk Factors for Hospitalization in People With HIV and COVID-19Kevin F Kamis, Lauren Barbera, Mona Abdo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 24, 2018
Tenofovir Diphosphate in Dried Blood Spots Is Strongly Associated With Viral Suppression in Individuals With Human Immunodeficiency Virus InfectionsJose R Castillo-Mancilla, Mary Morrow, Ryan P Coyle, et al.
The Journal of Infectious Diseases|April 4, 2019
Predictive Value of Tenofovir Diphosphate in Dried Blood Spots for Future Viremia in Persons Living With HIVMary Morrow, Samantha MaWhinney, Ryan P Coyle, et al.
The Journal of Antimicrobial Chemotherapy|March 27, 2020
Factors associated with tenofovir diphosphate concentrations in dried blood spots in persons living with HIVRyan P Coyle, Mary Morrow, Stacey S Coleman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 13, 2015
Reduced immune activation during tenofovir-emtricitabine therapy in HIV-negative individualsJose R Castillo-Mancilla, Amie Meditz, Cara Wilson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 24, 2016
Suboptimal Adherence to Combination Antiretroviral Therapy Is Associated With Higher Levels of Inflammation Despite HIV SuppressionJose R Castillo-Mancilla, Todd T Brown, Kristine M Erlandson, et al.
BMC Infectious Diseases|January 14, 2025
Blood absolute lymphocyte count and trajectory are important in understanding severe COVID-19Catharine I Paules, Jacqueline A Nordwall, Kathryn Shaw-Saliba, et al.
AIDS and Behavior|February 25, 2019
Engagement in Mental Health Care is Associated with Higher Cumulative Drug Exposure and Adherence to Antiretroviral TherapyRyan P Coyle, Christopher D Schneck, Mary Morrow, et al.
Pageof 8